XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Statement of Comprehensive Income [Abstract]    
Net loss $ (4,984,441) $ (9,793,324)
Available for sale securities - net unrealized loss (30,746) 0
Total other comprehensive loss (30,746) 0
Comprehensive loss (5,015,187) (9,793,324)
Comprehensive loss attributable to noncontrolling interests (1,862) (433,497)
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders $ (5,013,325) $ (9,359,827)